BUZZ - Eli Lilly shares rise after rival Novo Nordisk raises 2026 performance forecast
路透社2026/11/04 14:46November 4 - ** The pharmaceutical company Eli Lilly (LLY.N) saw its stock price rise 2%, reaching $1,437.28
** Eli Lilly's competitor Novo Nordisk reported third-quarter results that exceeded expectations and has (link) raised its full-year adjusted sales and operating profit forecasts to a range of 2% growth to a 2% decline at constant exchange rates, compared with the previous forecast of flat to a 6% decline
** Novo stated that the improvement in performance was mainly due to increased volume, particularly sales growth of its weight-loss drug Wegovy
** “For Eli Lilly, the strong demand for Wegovy further confirms our view that with broader market coverage, volume growth in this category will offset pricing pressure,” said Citi analyst Geoffrey Meacham
** Meacham noted that Novo Nordisk continues to face pressure in the U.S. market for its injectable diabetes and obesity medications, which further highlights the strong performance of Eli Lilly's injectable weight-loss drug Zepbound's active ingredient, tirzepatide
** Eli Lilly (LLY) shares have risen 31% so far this year
(For the convenience of non-native English speakers, Reuters provides automated translations of its reporting in several other languages. Automated translations may contain errors or lack necessary context. Reuters does not guarantee the accuracy of the automated translation and provides it purely for reader convenience. Reuters does not accept any liability for any damages or losses caused by the use of automated translation functions.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Tom Lee Says Democratic Sweep Could Fuel 15% to 20% Tech Rally
The Senate takes control, the White House can no longer appoint "its own people", has the Federal Reserve's independence alarm been lifted?
After the Senate changed hands, the White House's room to install its own people at the Federal Reserve has been significantly narrowed. JPMorgan economist Feroli pointed out that the only expiring Federal Reserve Board position in the next two years is Powell's chairmanship (January 2028). If the White House wants to fill it, it must nominate a candidate acceptable to the Democratic-controlled Senate; otherwise, the seat will remain vacant. Meanwhile, the political value of removing Board member Cook has therefore diminished, and current Chair Waller's path to reappointment is also facing new congressional public relations pressure.
BoJ Minutes: Members agree it was suitable for bank to keep increasing policy interest rate
Waymo and Uber (UBER.US) exclusive Robotaxi partnership in two cities will end in 2028
Waymo plans to end its exclusive Robotaxi partnership with Uber (UBER.US) in Austin and Atlanta in January 2028. At that time, customers will be able to book autonomous rides through the Waymo app.
Crypto prices
More
